CRO Appoints MediciGlobal for Patient Recruitment Services
MediciGlobal’s expertise and award winning team lend support to a Major Depressive Disorder clinical trial.
King of Prussia, PA (December 15, 2008) – A CRO, selected MediciGlobal, a leading specialty patient recruitment-retention firm, for the development of patient specific materials, for a Major Depressive Disorder clinical trial.
Major Depressive Disorder (MDD) also known as severe depression affects close to 15 million Americans. MediciGlobal is working with a CRO and its clinical project team, to develop comprehensive tools designed to assist research centers communicate the study to patients and their families.
With an expedited development timeline, MediciGlobal is delivering the patient materials within an agreed upon timeframe, and together, both companies are collaborating to closely monitor the progress of recruitment and the use of the materials.
“Major Depressive Disorder is a devastating disease,” said Liz Moench, CEO of MediciGlobal. “We are pleased to be working with this important CRO, and supporting the research centers to ensure that study staff has the best tools possible to communicate with MDD patients, and make the recruitment process a successful one.”
Since the conduct of MDD studies often involves familial support and or a coach, it is important that the patient’s supporters are also connected with the study, and understand its requirements related to time and commitment. “Materials with information that informs and guides patients as well as their supporters are important for recruitment and retention” says Moench. “In fact, effectively designed materials can account for 30% of patient and family response, and garners the commitment of study staff.”
###
About MediciGlobal
MediciGlobal is in the business of making a meaningful difference to patient health—by identifying and engaging patients for clinical trials, and by building deep and lasting connections with our many stakeholders. Our clinical trial recruitment practices are guided by global standards and by our concern for the lives of the patients who put their trust in us. We’re also making certain that those who participate in these trials fully understand what clinical trial participation means, and that their participation is guarded by strict privacy policies. MediciGlobal meets BBB OnLine® and WBENC accreditation standards and is certified as a Safe Harbor company. Visit www.mediciglobal.com and follow the company on Facebook at www.facebook.com/MediciGlobal.
www.mediciglobal.com
For further information contact:
Alicia Carango
+1 484-674-6855
acarango@MediciGlobal.com
